SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-033602
Filing Date
2020-07-27
Accepted
2020-07-27 16:41:01
Documents
59
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20200630.htm   iXBRL 10-Q 1756773
2 EX-10.1 crsp-ex101_293.htm EX-10.1 900868
3 EX-31.1 crsp-ex311_8.htm EX-31.1 19180
4 EX-31.2 crsp-ex312_6.htm EX-31.2 19435
5 EX-32.1 crsp-ex321_7.htm EX-32.1 7719
  Complete submission text file 0001564590-20-033602.txt   7005033

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crsp-20200630.xsd EX-101.SCH 49866
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20200630_cal.xml EX-101.CAL 42397
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20200630_def.xml EX-101.DEF 140016
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20200630_lab.xml EX-101.LAB 369689
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20200630_pre.xml EX-101.PRE 267648
11 EXTRACTED XBRL INSTANCE DOCUMENT crsp-10q_20200630_htm.xml XML 869857
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 201050839
SIC: 2836 Biological Products, (No Diagnostic Substances)